94 filings
6-K
LSB
LakeShore Biopharma Co., Ltd
8 Oct 24
Report of Foreign Private Issuer
8:59am
6-K
LSB
LakeShore Biopharma Co., Ltd
27 Sep 24
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
7:15am
6-K/A
LSB
LakeShore Biopharma Co., Ltd
10 Sep 24
Current report (foreign) (amended)
4:00pm
6-K
LSB
LakeShore Biopharma Co., Ltd
10 Sep 24
Report of Foreign Private Issuer
8:15am
6-K
LSB
LakeShore Biopharma Co., Ltd
4 Sep 24
LakeShore Biopharma Announces Leadership Transitions
8:10am
6-K
4coyb34bvc84ec
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
NT 20-F
gkmlw
31 Jul 24
Notice of late annual filing (foreign)
7:15am
6-K
77p5lrnd m0fhkw
5 Jul 24
Report of Foreign Private Issuer
7:15am
6-K
qrhufkaz9ckh5w8536a
18 Jun 24
Report of Foreign Private Issuer
7:30am
6-K
p9vgm7qgs4r3d3u66
10 Jun 24
Report of Foreign Private Issuer
7:01am
6-K
6s5c2tcy
24 May 24
YS Biopharma Announces Name Change to LakeShore Biopharma
7:45am
6-K
ce9 mwixu2u5u
21 May 24
YS Biopharma Announces Results of Extraordinary General Meeting
4:30pm
S-8
c87 gxfhsud
20 May 24
Registration of securities for employees
4:16pm
424B3
7jn6d0i5 q0
8 May 24
Prospectus supplement
8:32am
6-K
v3lfy
7 May 24
Report of Foreign Private Issuer
4:30pm
6-K
96rlpky22160b0l
29 Apr 24
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
8:15am
6-K
zzik0sxh
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
6-K
n0qoz
18 Apr 24
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
8:15am
6-K
cufy c2lbkl
9 Apr 24
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
8:20am